Evidence map›Paper›PMID 32572964›Full record

ArticleJournal of cellular physiology2021

Irisin deficiency disturbs bone metabolism.

Xiaofang Zhu, Xiangfen Li, Xiaoxuan Wang, Ting Chen, Fengjuan Tao, Chuanju Liu, Qisheng Tu, Guofang Shen, Jake J Chen

Open access · greenAbstract read
In one paragraph

Article in Journal of cellular physiology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 44 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
44citing papers in PubMed, 1 pooled it
4.9field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

44 citing papers in PubMed, 1 synthesis or guideline pooled it, 66 citations in OpenAlex.

  1. Protective role of irisin on bone in osteoporosis: a systematic review of rodent studies.Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA · 2025
    Pooled it
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Review
  12. Review
  13. Review
  14. Review
  15. Review
  16. Review
  17. Article
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 2 countries.

Xiaofang ZhuDepartment of Oral & Cranio-Maxillofacial Surgery, Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai Key Laboratory of Stomatology, Shanghai, China.ORCID 0000-0001-8083-0212
Xiangfen LiDivision of Oral Biology, Tufts University School of Dental Medicine, Boston, Massachusetts.
Xiaoxuan WangDivision of Oral Biology, Tufts University School of Dental Medicine, Boston, Massachusetts.
Ting ChenDivision of Oral Biology, Tufts University School of Dental Medicine, Boston, Massachusetts.
Fengjuan TaoDivision of Oral Biology, Tufts University School of Dental Medicine, Boston, Massachusetts.
Chuanju LiuDepartment of Orthopedics Surgery and Department of Cell Biology, New York University School of Medicine, New York, New York.
Qisheng TuDivision of Oral Biology, Tufts University School of Dental Medicine, Boston, Massachusetts.
Guofang ShenDepartment of Oral & Cranio-Maxillofacial Surgery, Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai Key Laboratory of Stomatology, Shanghai, China.
Jake J ChenDivision of Oral Biology, Tufts University School of Dental Medicine, Boston, Massachusetts.
Tufts University · USNew York University · USShanghai Jiao Tong University · CN

Funding

The immunological mechanism of PGRNs anti-inflammatory effect - Renewal - 1R01AR062207 · NIAMS · YALE UNIVERSITY · PI Chuanju Liu · 2012 to 2026
$5.6M
Roles of Noncoding RNA in Bone RegenerationR01DE025681 · NIDCR · TUFTS UNIVERSITY BOSTON · PI CHEN, JAKE JINKUN · 2016 to 2024
$4.5M
A Long Noncoding RNA Amerliorates Periodontitis via Distinct Epigenetic PathwaysR01DE030074 · NIDCR · TUFTS UNIVERSITY BOSTON · PI CHEN, JAKE JINKUN · 2021 to 2025
$3.5M
Alveolar Bone Regeneration in Diabetic PeriodontitisR01DE026507 · NIDCR · TUFTS UNIVERSITY BOSTON · PI CHEN, JAKE JINKUN · 2017 to 2021
$2.0M
Therapeutic Strategies for Treating Type 2 Diabetes Mellitus -Associated PeriodonR01DE021464 · NIDCR · TUFTS UNIVERSITY BOSTON · PI CHEN, JAKE JINKUN · 2011 to 2013
$1.3M
NIAMS NIH HHS R01 AR062207NIDCR NIH HHS R01 DE021464NIDCR NIH HHS R01 DE025681NIDCR NIH HHS R01 DE026507NIDCR NIH HHS R01 DE030074
6 · The paper itself

Abstract

Balancing the process of bone formation and resorption is important in the maintenance of healthy bone. Therefore, the discovery of novel factors that can regulate bone metabolism remains needed. Irisin is a newly identified hormone-like peptide. Recent studies have reported the involvement of irisin in many physiological and pathological conditions with bone mineral density changes, including osteopenia and osteoporotic fractures. In this study, we generated the first line of Osx-Cre:FNDC5/irisin KO mice, in which FNDC5/irisin was specifically deleted in the osteoblast lineage. Gene and protein expressions of irisin were remarkably decreased in bones but no significant differences in other tissues were observed in knockout mice. FNDC5/irisin deficient mice showed a lower bone density and significantly delayed bone development and mineralization from early-stage to adulthood. Our phenotypical analysis exhibited decreased osteoblast-related gene expression and increased osteoclast-related gene expression in bone tissues, and reduced adipose tissue browning due to bone-born irisin deletion. By harvesting and culturing MSCs from the knockout mice, we found that osteoblastogenesis was inhibited and osteoclastogenesis was increased. By using irisin stimulated wildtype primary cells as a gain-of-function model, we further revealed the effects and mechanisms of irisin on promoting osteogenesis and inhibiting osteoclastogenesis in vitro. In addition, positive effects of exercise, including bone strength enhancement and body weight loss were remarkably weakened due to irisin deficiency. Interestingly, these changes can be rescued by supplemental administration of recombinant irisin during exercise. Our study indicates that irisin plays an important role in bone metabolism and the crosstalk between bone and adipose tissue. Irisin represents a potential molecule for the prevention and treatment of bone metabolic diseases.

Indexed as

Bone and BonesFibronectinsMuscle, SkeletalOsteoblastsOsteogenesisAnimalsBone Diseases, MetabolicMiceFibronectinsFNDC5 protein, mousebone metabolismbone mineralizationconditional knockoutirisin/FNDC5

Identifiers

PMID32572964
PMCPMC7722136
OpenAlexW3037145231

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.